These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29419534)

  • 41. Pharmacological treatment of pure stress urinary incontinence: a narrative review.
    Malallah MA; Al-Shaiji TF
    Int Urogynecol J; 2015 Apr; 26(4):477-85. PubMed ID: 25630399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.
    Kwakye IN; Garner M; Baldwin DS; Bamford S; Pinkney V; Bishop FL
    Hum Psychopharmacol; 2016 Jul; 31(4):332-40. PubMed ID: 27378326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Duloxetine for chronic pain management: pharmacology and clinical use].
    Masuda R; Itoh M; Suzuki T
    Masui; 2013 Jul; 62(7):814-21. PubMed ID: 23905404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute Urinary Retention and Acute Kidney Injury After Duloxetine Treatment: A Rare Case Report.
    Aktürk Esen S; Gül CB; Kahvecioğlu S; Aktaş N; Esen İ
    J Clin Psychopharmacol; 2019; 39(3):279-281. PubMed ID: 30908353
    [No Abstract]   [Full Text] [Related]  

  • 45. Coping with somatic comorbidities: striving for complete recovery.
    Allgulander C; Kasper S
    Psychopharmacol Bull; 2002; 36 Suppl 2():103-11. PubMed ID: 12490826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats.
    Handa J; Sekiguchi M; Krupkova O; Konno S
    Eur Spine J; 2016 Mar; 25(3):877-87. PubMed ID: 26394856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
    Islin J; Munkboel CH; Styrishave B
    Toxicol In Vitro; 2018 Mar; 47():63-71. PubMed ID: 29100959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord.
    Zhang TT; Xue R; Fan SY; Fan QY; An L; Li J; Zhu L; Ran YH; Zhang LM; Zhong BH; Li YF; Ye CY; Zhang YZ
    J Neuroinflammation; 2018 Jun; 15(1):176. PubMed ID: 29879988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysosmia and dysgeusia associated with duloxetine.
    Yoshida K; Fukuchi T; Sugawara H
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT
    Xu X; Wei Y; Guo Q; Zhao S; Liu Z; Xiao T; Liu Y; Qiu Y; Hou Y; Zhang G; Wang K
    J Pharmacol Exp Ther; 2018 Jun; 365(3):624-635. PubMed ID: 29615471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
    Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatal overdose with a combination of SNRIs venlafaxine and duloxetine.
    Alibegović A; Kariž S; Volavšek M
    Forensic Sci Med Pathol; 2019 Jun; 15(2):258-261. PubMed ID: 30796754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of Depression With Duloxetine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes.
    Cozart B; Diaz Vera J; Denham JD; Whiting WL
    Clin Neuropharmacol; 2018; 41(3):103-105. PubMed ID: 29596118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidepressant agents for the treatment of chronic pain and depression.
    Jann MW; Slade JH
    Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duloxetine in Patients With Kidney Disease: "A Great Deal of Intelligence Can Be Invested in Ignorance When the Need for Illusion Is Deep": Saul Bellow.
    Braillon A
    Am J Ther; 2018; 25(6):e760-e761. PubMed ID: 29782341
    [No Abstract]   [Full Text] [Related]  

  • 58. Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Am J Health Syst Pharm; 2013 Dec; 70(24):2207-17. PubMed ID: 24296843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
    Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
    Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.